Diabetes Obes Metab (2016) 18(3):25865
Absolutely but get it from Red Fox Peptides and not just any source
Lengsfeld, S., Hasenbohler, F., Probst, L., Baur, F., Emara, Y., Bathelt, C., Werlen, L., Vogt, D., Caviezel, B., Vukajlovic, T., Christ-Crain, M., & Winzeler, B
As a result, acetyl-CoA carboxylase activity was reduced, fatty acid oxidation induced (due to decreased malonyl-CoA), and the expression of lipogenic enzymes along with SREBP-1, a key lipogenic transcription factor, suppressed [72]
What we'd expect long-term based on available data: Weight loss continues through at least 104 weeks in most patients Estimated peak loss: 3032% in patients reaching maximum dose and maintaining treatment Maintenance phase: stable weight if treatment continues without dose reduction Weight regain after stopping is near-universal with all GLP-1 medications
Goals: You can discuss the health outcomes youre hoping for, whether thats more energy, better function, and improved labs, as well as weight loss
